|
|
 |
| |
|
Home > Drug Companies > Gate Pharmaceuticals
Gate Pharmaceuticals
Gate Pharmaceuticals was created in 1990 to market innovative pharmaceutical products in the United States. Their strategic focus is the treatment of central nervous system disorders. Gate Pharmaceuticals is a division of Teva Pharmaceuticals USA, a subsidiary of Teva Pharmaceutical Industries, Ltd., Israel's leading pharmaceutical company. At Gate Pharmaceuticals, they combine the creative spirit of a small company with the experience and resources of a respected global corporation.
At Gate Pharmaceuticals, they are proud of their ability to manufacture and market products that make a difference in people's lives. Since their inception in 1990, Gate Pharmaceuticals has marketed a weight loss drug. They have also made a presence in the field of neurology with a treatment for Tourette Syndrome, and in the field of cardiology with a treatment for high cholesterol, and in the field of oncology with a drug to treat acute lymphatic leukemia. Just this year Gate Pharmaceuticals introduced a new human growth hormone.
As they move into the 21st century, Gate Pharmaceuticals is continuing to explore new ways to bring innovative, effective medications to patients and the HealthCare community. Their mission is to be a prominent niche market provider in the pharmaceutical industry, succeeding with a select team of highly trained people dedicated to improving lives through better medicine.
Gate Pharmaceuticals works regularly with renowned medical and pharmaceutical professionals committed to bringing unique, value-added therapies that help heal, protect and beautify the skin. This mission statement guides them in their work and reminds them of their commitments. They shall provide an environment to encourage commitment, teamwork and continuous improvement of our products and personnel. Quality is not just another goal, it is their basic strategy for future growth.
Back to Drug Companies
|
|
|
|
|
|
|
|